McKesson Corporation vs Cardinal Health, Inc.
A head-to-head of McKesson Corporation (MCK) and Cardinal Health, Inc. (CAH) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | MCK | CAH |
|---|---|---|
| Market Cap | $98.51B | $53.52B |
| P/E (TTM) | 21.92 | 34.94 |
| Forward P/E | 15.14 | 18.99 |
| P/S | 0.23 | 0.18 |
| P/B | -42.09 | -15.98 |
| EV/EBITDA | 14.44 | 12.49 |
| Dividend Yield | 0.16% | 0.79% |
| Profit Margin | 1.18% | 0.62% |
| Gross Margin | 3.61% | 3.67% |
| Operating Margin | 1.60% | 1.04% |
| Revenue Growth (YoY) | +6.02% | +11.05% |
| FCF Yield | 5.91% | 9.56% |
| Debt / Equity | — | — |
| Current Ratio | 0.85 | 0.91 |
Which is better: McKesson Corporation or Cardinal Health, Inc.?
- ✓Larger by market cap: McKesson Corporation
- ✓Cheaper valuation (lower P/E): McKesson Corporation
- ✓Higher dividend yield: Cardinal Health, Inc.
- ✓More profitable (net margin): McKesson Corporation
- ✓Faster revenue growth: Cardinal Health, Inc.
- ✓Higher free-cash-flow yield: Cardinal Health, Inc.
Across 11 available metrics, Cardinal Health, Inc. leads 7–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.